Invaio Sciences is a multi-platform technology company that unlocks the potential of the planet's interdependent systems to address pressing agricultural, nutritional, and environmental challenges.
Founded by Flagship Pioneering in 2018, Invaio leverages discoveries from diverse fields including human therapeutics, agriculture, environmental science, and advanced manufacturing. The company's deep understanding of the physiology of insects, plants and trees, together with its novel integrated solutions approach, promises to refine agricultural practices and reduce the need for pesticides globally. Invaio Sciences is dedicated to developing solutions that are mindful of beneficial insects, bad for pests, and safer for us all.
Founded by Flagship Pioneering in 2018, Invaio leverages discoveries from diverse fields including human therapeutics, agriculture, environmental science, and advanced manufacturing. The company's deep understanding of the physiology of insects, plants and trees, together with its novel integrated solutions approach, promises to refine agricultural practices and reduce the need for pesticides globally. Invaio Sciences is dedicated to developing solutions that are mindful of beneficial insects, bad for pests, and safer for us all.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $139M
Founded date: 2018
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.10.2021 | - | $50M | Flagship P... |
| 25.05.2021 | Series C | $89M | - |
Mentions in press and media 19
| Date | Title | Description |
| 10.07.2024 | Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability | Record Year with Key Partnerships, Global Expansion and Expanded Top Talent CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced it has expanded its capital base by $3.6 bi... |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 11.12.2023 | Why Invaio Sciences acquired Peptyde Bio: ‘Peptides represent a major opportunity for biologicals’ | Biotech platform Invaio Sciences has acquired Peptyde Bio, a Missouri-based startup that makes biofungicide tech for agriculture. Working together, the two teams will be able to speed up development of and access to sustainable crop inputs.... |
| 08.12.2023 | Invaio Sciences Acquires Peptyde Bio | Invaio Sciences, a Cambridge, MA-based provider of a nature-positive solutions for farmers, acquired Peptyde Bio, a Cambridge, MA-based company that discovers, designs and characterizes novel peptides for use in agriculture. The amount of t... |
| 08.12.2023 | Invaio Sciences Acquires Peptyde Bio To Accelerate Nature-positive Crop Protection Pipeline | Invaio well positioned to bring effective and reliable biological actives to growers Invaio Sciences announced it has acquired Peptyde Bio, a company that discovers, designs and characterizes novel peptides for use in agriculture. The acqui... |
| 13.10.2021 | Invaio Sciences : Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change | CAMBRIDGE, Mass., Oct. 13, 2021 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company unlocking the potential of natural systems to accelerate the transition to sustainable agriculture to urgently address climate change, has ... |
| 13.10.2021 | Invaio Sciences Receives $50M in Debt Financing | Invaio Sciences, Inc., a Cambridge, Mass.-based Flagship Pioneering company unlocking the potential of natural systems to accelerate the transition to sustainable agriculture to address climate change, entered into a $50m loan and security ... |
| 08.07.2021 | BREAKING: Micropep’s small peptide ag inputs get $10m from FMC, others | Micropep Technologies, a startup developing peptide-based biological inputs for farms, has raised €8.5 million ($10 million) in Series A funding. The round was led by Paris-based Supernova Invest. FMC Ventures, the corporate VC arm of US ag... |
| 08.07.2021 | Micropep’s small peptide ag inputs get $10m from FMC, others | Micropep Technologies, a startup developing peptide-based biological inputs for farms, has raised €8.5 million ($10 million) in Series A funding. The round was led by Paris-based Supernova Invest. FMC Ventures, the corporate VC arm of US ag... |
| 14.06.2021 | Brief: Flagship closes $3.4bn fund to build ‘bioplatform’ companies in ag, nutrition & health | Flagship Pioneering, the fund manager and company formation group, has closed its seventh fund on $3.4 billion after re-opening it to existing investors and a “select” group of new backers. The close takes Flagship’s total assets under mana... |
Show more